Glaukos (GKOS) vs Merit Medical Systems (MMSI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Glaukos (GKOS) has outperformed Merit Medical Systems (MMSI) over the past year, gaining 104.8% versus a gain of 2.9%. Over five years, GKOS leads with a +284.2% price change compared with +22.3% for MMSI. Glaukos is the larger company by market cap ($9.32 billion vs $5.09 billion), about 1.8 times the size.
On valuation, Merit Medical Systems trades at a lower forward P/E (18.5x vs 301.7x for Glaukos). Merit Medical Systems converts more of its revenue into profit, with a net margin of 8.5% versus -37.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GKOS | MMSI |
|---|---|---|
| Share price | $157.95 | $85.27 |
| Market cap | $9.32B | $5.09B |
| 1-day change | -8.26% | +0.21% |
| YTD return | +52.49% | -3.46% |
| 1-year return | +104.76% | +2.89% |
| 5-year return | +284.16% | +22.27% |
| P/E ratio (TTM) | — | 35.09 |
| Forward P/E | 301.68 | 18.49 |
| EPS (TTM) | $-3.26 | $2.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $507.44M | $1.52B |
| Revenue growth (YoY) | +32.33% | +11.75% |
| Net income (latest FY) | $-187.69M | $128.49M |
| Gross margin | 55.72% | 48.70% |
| Operating margin | -39.33% | 12.19% |
| Net margin | -36.99% | 8.48% |
| 52-week high | $191.62 | $94.75 |
| 52-week low | $73.16 | $59.74 |
| Distance from 52-week high | -17.57% | -10.01% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +25.79% | +18.98% |
| Average volume | 798.61K | 795.56K |
| Shares outstanding | 58.98M | 59.71M |
| Employees | 1,094 | 7,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GKOS has outperformed MMSI by 101.9 percentage points over the past year.
- Merit Medical Systems is more profitable, keeping 8.5 cents of every revenue dollar as net income versus -37.0 cents for Glaukos.
- Glaukos grew revenue faster in its latest fiscal year (+32.33% vs +11.75%).
About Glaukos
GKOS stock →Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.
Health Care · Medical/Dental Instruments · 1,094 employees
About Merit Medical Systems
MMSI stock →Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Health Care · Medical/Dental Instruments · 7,500 employees
GKOS vs MMSI FAQ
Which is bigger, Glaukos or Merit Medical Systems?
Glaukos (GKOS) is larger, with a market capitalization of $9.32B compared with $5.09B for Merit Medical Systems (MMSI).
Which stock has performed better over the past year, GKOS or MMSI?
GKOS returned +104.76% over the past 12 months, compared with +2.89% for MMSI (price return, excluding dividends). Past performance does not predict future results.
Are Glaukos and Merit Medical Systems in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.